These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging. Lin CH; Yang HT; Chiu CC; Lane HY Sci Rep; 2017 Nov; 7(1):14849. PubMed ID: 29093468 [TBL] [Abstract][Full Text] [Related]
3. Depressive symptoms and anti-N-methyl-D-aspartate-receptor GluN1 antibody seropositivity in the PROSpective cohort with incident stroke. Sperber PS; Gebert P; Broersen LHA; Kufner A; Huo S; Piper SK; Teegen B; Heuschmann PU; Prüss H; Endres M; Liman TG; Siegerink B Brain Behav Immun Health; 2023 Dec; 34():100705. PubMed ID: 38033615 [TBL] [Abstract][Full Text] [Related]
5. Serum IgG antibodies against the NR1 subunit of the NMDA receptor not detected in schizophrenia. Masdeu JC; González-Pinto A; Matute C; Ruiz De Azúa S; Palomino A; De Leon J; Berman KF; Dalmau J Am J Psychiatry; 2012 Oct; 169(10):1120-1. PubMed ID: 23032395 [No Abstract] [Full Text] [Related]
6. The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link? Hermida AP; McDonald WM; Steenland K; Levey A Expert Rev Neurother; 2012 Nov; 12(11):1339-50. PubMed ID: 23234395 [TBL] [Abstract][Full Text] [Related]
7. Pharmacophore-driven identification of N-methyl-D-receptor antagonists as potent neuroprotective agents validated using Sharma M; Mittal A; Singh A; Jainarayanan AK; Sharma S; Paliwal S Biol Methods Protoc; 2020; 5(1):bpaa013. PubMed ID: 32913897 [TBL] [Abstract][Full Text] [Related]
13. Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-D-aspartate glutamate receptor antibodies in dementias. Busse M; Kunschmann R; Dobrowolny H; Hoffmann J; Bogerts B; Steiner J; Frodl T; Busse S Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):483-492. PubMed ID: 28176002 [TBL] [Abstract][Full Text] [Related]
14. Brain-targeting autoantibodies in patients with dementia. Staabs F; Foverskov Rasmussen H; Buthut M; Höltje M; Li LY; Stöcker W; Teegen B; Prüss H Front Neurol; 2024; 15():1412813. PubMed ID: 39050125 [TBL] [Abstract][Full Text] [Related]
15. Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond. Garmendia JV; De Sanctis CV; Das V; Annadurai N; Hajduch M; De Sanctis JB Curr Neuropharmacol; 2024; 22(6):1080-1109. PubMed ID: 37898823 [TBL] [Abstract][Full Text] [Related]
16. Autoimmunity and Frontotemporal Lobar Degeneration: From Laboratory Study to Clinical Practice. Sun Y; Zhang L; Liu P; Peng G Clin Interv Aging; 2023; 18():495-503. PubMed ID: 37008802 [TBL] [Abstract][Full Text] [Related]
17. The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer's Disease. Ehtezazi T; Rahman K; Davies R; Leach AG J Alzheimers Dis Rep; 2023; 7(1):173-211. PubMed ID: 36994114 [TBL] [Abstract][Full Text] [Related]
18. Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders. Morozova A; Zorkina Y; Abramova O; Pavlova O; Pavlov K; Soloveva K; Volkova M; Alekseeva P; Andryshchenko A; Kostyuk G; Gurina O; Chekhonin V Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163141 [TBL] [Abstract][Full Text] [Related]
19. Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis. Theorell J; Ramberger M; Harrison R; Mgbachi V; Jacobson L; Waters P; Erhardt S; Sellgren CM; Cervenka S; Piehl F; Irani SR Transl Psychiatry; 2021 Nov; 11(1):566. PubMed ID: 34741015 [TBL] [Abstract][Full Text] [Related]